ArticleNanoImpact2025
Development and characterization of reference environmentally relevant micro-nano-plastics for risk assessment studies.
Article in NanoImpact, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Microplastics and nanoplastics in inflammatory bowel disease: Mechanistic plausibility, human evidence and future research priorities.World journal of gastrointestinal pathophysiology · 2026Review
- Lifecycle Implications of Poly(vinyl chloride) (PVC) Micro(nano)plastics (MNPs): Interactions with Coexposed Environmental Pollutants (EPs) and Impact on Their Toxicity and Bioavailability.Environmental science & technology · 2026Article
- Nanoplastics and Neurodegeneration: A Roadmap From Mechanism to Causation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Emerging cardiovascular risks of micro- and nanoplastics: toxic effects and mechanistic pathways.Particle and fibre toxicology · 2026Review
- Article
- Article
- Hydrophobins fromEnvironmental science & technology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Micro- and nano-plastics (MNPs) have become ubiquitous environmental pollutants. Extensive toxicological studies of MNPs have been conducted in recent years. However, because of the difficulties involved in extraction and collection of MNPs from environmental media, most of these studies have employed simplistic, pristine, spherical, micro- or nano-sized commercial MNPs, whose properties, including morphology, surface chemistry, and size, do not adequately approximate those of environmentally relevant MNPs. Here, we describe the development and use of methods for the synthesis of well characterized, environmentally relevant MNPs across the life cycle of a plastic material, in a property-controlled manner. Multiple degradation scenarios, including mechanical fragmentation (cryogenic milling), UV weathering, and thermal disintegration (incineration) were applied to virgin plastic materials (polyvinyl chloride, PVC; polyethylene terephthalate, PET; High density polyethylene, HDPE; Acrylonitrile butadiene styrene, ABS; polycarbonate, PC; and polypropylene, PP) to simulate the life cycle pathways that likely occur in the environment over time. The MNPs generated from these degradation processes were size fractionated using both "dry" and "wet" separation methods. Detailed physicochemical characterization of the size fractionated reference MNPs was performed to determine size, morphology, chemical and elemental compositions, and hydrophobicity. Microbiological sterility and endotoxin content of reference MNPs were also assessed. Protocols for storage of reference MNPs in controlled oxygen and moisture conditions for future use in toxicological studies are also described. The methodology developed in this study can be used to synthesize environmentally relevant reference MNPs across the life cycle of plastic materials for use in risk assessment studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.